National Clinical Guideline for the Diagnosis, Staging and Treatment of Prostate Cancer

The NCCP have now updated the radiology and diagnosis sections of the National Clinical Guideline No. 8 Diagnosis, Staging and Treatment of Patients with Prostate Cancer.

The updated section ‘Diagnosis and Staging of patients with prostate cancer (2022)’ can be found below. Please note the updated section (2022) now supersedes the recommendations of the diagnostic section within the National Clinical Guideline No. 8 Diagnosis, Staging and Treatment of Patients with Prostate Cancer (2015).

Guidelines

 

Diagnosis and Staging of patients with prostate cancer (2022)

null

For men with prostate cancer post definitive surgical or radiotherapy treatment, what is the optimum follow up protocol to monitor for a biochemical prostate cancer recurrence? (2023)

 PCa_F2-Prostate-Surveillance-V1-cover

National Clinical Guideline No. 8 Diagnosis, Staging and Treatment of Patients with Prostate Cancer (2015)

NCEC Guideline_Prostate Cover
   

 

Consensus Statement 

Prostate Cancer Moderate Hypofractionation Interim Recommendations Consensus Group Statement June 2023

Last updated: 11/09/2023